Meaning of assisted breast cancer treatment
The importance of assisted treatment for breast cancer: Breast cancer assistance is a series of treatments, after the surgical treatment, aimed at eliminating the small cancer cells that may remain, reducing the risk of relapse and transfer, and improving the survival and quality of life of patients. These include chemotherapy, endocrine treatment, target treatment and immunotherapy. The significance of assisted treatment for breast cancer lies in its ability to provide individualized treatments tailored to the specific situation of the patient, thus achieving better treatment.
Improving survival rates and preventing relapses: The primary objective of assisted breast cancer treatment is to increase the survival rate of patients. Complementary chemotherapy can eliminate micro-transfer stoves that cannot be removed from the operation and reduce the risk of re-emergence at a distance. Endocrine treatment is aimed at hormonal receptor-positive breast cancer, which inhibits tumor growth by regulating hormone levels. Target treatment and immunotherapy provide more precise treatments for specific molecular markers and immune settings.
Improving the quality of life: Supported breast cancer treatment is concerned not only with its effects but also with the quality of life of patients. Newly assisted chemotherapy, for example, can bring down some of the otherwise non-surgery breast cancer, provide patients with the opportunity to operate, or even have the possibility of breast protection, so that breast integrity and beauty are maintained while treating the disease.
Individualized treatment strategy: An important trend in assisted breast cancer treatment is individualized treatment. Depending on the molecular stratification of the patient, his or her tumour characteristics and the overall condition of the patient, the doctor can develop the most suitable treatment for the patient. For example, patients with HeR2-positive breast cancer may benefit from combined chemotherapy against HeR2 treatment, while patients with triple-negative breast cancer may benefit from a combination of chemotherapy and immunotherapy.
Progress of the latest research: The latest study shows that assisted breast cancer treatment is improving. For example, the TCbHP (Doscitra, Capricorn, Cartomic Monopathy, Pattomosis) programme has become the cornerstone of the new complementary treatment for positive breast cancer, while T-DM1 has become the preferred option for follow-up assisted treatment for patients who have not reached a full pathological relief after the new assisted treatment. Among the new assisted treatments for triple-negative breast cancer, the programme of joint chemotherapy immunization has also shown excellent efficacy, providing patients with more treatment options.
In conclusion, assisted breast cancer treatment plays an important role in improving the survival of patients, preventing relapse, improving the quality of life and achieving individualized treatment. The treatment of breast cancer patients and the quality of life are expected to improve further as research is developed and treatment methods optimized.
Breast cancer
